India is poised to become Asia’s premier listing hub, building on its IPO boom and strong domestic investor base. By refining key pillars like institutional capital, research, governance, listing processes, and valuation frameworks, the nation can attract global companies and solidify its position as a leading financial center.Read More
Sudeep Pharma IPO: Shares are seeing solid momentum in the grey market, trading at a 21.92% premium to the issue price of ₹593. At this GMP, the stock is expected to list near ₹723, signalling a potential upside of about ₹130 per share.Read More
India’s five publicly listed REITs distributed over Rs 2,331 crore to unitholders in Q2 FY26, managing assets worth Rs 2.35 lakh crore. The sector’s market capitalization surpassed Rs 1.6 lakh crore, highlighting investor confidence and the growing maturity of this asset class in India’s capital markets.Read More
India’s stock market has underperformed global peers due to stretched valuations and a dip in earnings growth. However, a consumption boom fueled by fiscal stimulus and rate cuts is expected to drive earnings recovery from Q3 FY26, potentially triggering a market rally. Global trends, especially US developments, will also play a crucial role.Read More
Nvidia’s blockbuster earnings shattered fears of an AI slowdown, delivering a record revenue beat and reigniting a global tech rally. Surging demand for Blackwell GPUs, strong guidance, and accelerating data-center growth helped silence AI doomsday narratives. Markets across Asia rallied sharply as investors regained confidence that the AI boom is far from losing momentum.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
